Adagio Medical Holdings, Inc.

ADGM

Healthcare Medical Devices

Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023.

Revenue
−33.5%
EPS
−15.4%
Free cash flow
−12.9%
Total debt
+46.6%

Quarter to June 2026, against a year earlier

0.06 0.00 0.00%
Market cap
$1.8M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−74.6%
Net debt / EBITDA
−0.2×
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(208.48%) (155.25%) (268.88%) (657.76%)
ROA
(113.07%) (54.71%) (60.43%) (77.80%)
ROIC
(311.92%) (83.74%) (78.46%) (74.60%)
Return on Tangible Assets
(55,238.03%) (187.42%) (283.10%) (637.89%)
Average Days of Receivables
— — — —
Free Cash Flow per Share
(1.53) (1.17) (0.72) (0.75)
Free Cash Flow
(23.55) (19.39) (15.97) (16.57)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026